Syngene International Ltd.

Syngene is a leading global CRDMO with over 30 years of experience solving complex R&D challenges, delivering integrated drug discovery, development and manufacturing services across small and large molecules, including niche modalities such as ADCs, peptides and oligonucleotides. The company offers elite-level client-centricity, a robust supply chain and scientific excellence at scale, partnering with global pharma and biotech leaders from discovery through commercial manufacturing to shape the future of science.